Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease

Alpha-fetoprotein is an autoantigen in hepatocellular carcinoma and juvenile Batten disease

Failure of immune tolerance leads to production of autoantibodies to self-antigens. The repertoire of autoantibodies detected in cancer patients can indicate the presence of autoimmune disease. Alpha-fetoprotein (AFP) autoantibodies have been found in patients with hepatocellular carcinoma (HCC) and...

Full description

Bibliographic Details
Main Authors:	Roberto Bei, Gerald J. Mizejewski
Format:	Article
Language:	English
Published:	IMR Press 2020-01-01
Series:	Frontiers in Bioscience-Landmark
Subjects:	alpha-fetoprotein autoimmunity antigens epitopes disordered protein autoimmune disorders batten disease review
Online Access:	https://www.imrpress.com/journal/FBL/25/5/10.2741/4840

Similar Items

Identification of α-fetoprotein as an autoantigen in juvenile Batten disease
by: Julian A. Castaneda, et al.
Published: (2008-01-01)

HEPATOCELLULAR CARCINOMA: CORRELATION OF ALPHA-FETOPROTEIN WITH TUMOUR CHARACTERISTICS
by: Rafi Ud Din, et al.
Published: (2020-04-01)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein
by: Toru Setsu, et al.
Published: (2017-03-01)

ALPHA-FETOPROTEIN AS ANTI-AGING AGENT: EFFECT ON SURVIVAL AND AGE-MARKERS IN MICE
by: V I Dontsov, et al.
Published: (2016-12-01)

Clinical value of alpha-fetoprotein: alpha-fetoprotein-L3 isoform ratio and des-γ-carboxyprothrombin in early diagnosis of HBV-related hepatocellular carcinoma
by: Duan Jianping, Du Lei, Song Ting, Liu Zhensheng
Published: (2023-08-01)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
by: Ye Xu, et al.
Published: (2021-10-01)

ASSOCIATION OF SERUM ALPHA FETOPROTEIN (AFP) LEVELS WITH SIZE OF HEPATOCELLULAR CARSINOMA
by: Khawar Sahbbir, et al.
Published: (2019-02-01)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
by: Jian Huang, et al.
Published: (2020-04-01)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
by: Jian Hu, et al.
Published: (2018-12-01)

Alpha-Fetoprotein (AFP): Solved and Unsolved Problems
by: Garry Abelev, et al.
Published: (2020-12-01)

Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas
by: Sejong Chun, et al.
Published: (2015-11-01)

Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
by: Brianna Ruch, et al.
Published: (2022-10-01)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
by: Jianping Sun, et al.
Published: (2019-10-01)

Sunflower-Like Nanostructure with Built-In Hotspots for Alpha-Fetoprotein Detection
by: Xiaoyu Zhao, et al.
Published: (2021-02-01)

The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels
by: Chia-Chu Fu, et al.
Published: (2023-07-01)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
by: Yurong Wang, et al.
Published: (2018-05-01)

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01)

Correlation of Abdominal CT scan Score and Alpha-fetoprotein Levels in Hepatocellular Carcinoma
by: Indira Prawita Martani, et al.
Published: (2022-09-01)

Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
by: Joo Hyun Oh, et al.
Published: (2023-12-01)

Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative study
by: Ahmed Haitham Abduljabbar
Published: (2023-02-01)

The Maternal Serum Alpha-Fetoprotein for Congenital Anomalies Screening
by: Patria Dewi Pande, et al.
Published: (2023-05-01)

A case of alpha-fetoprotein-producing esophageal adenocarcinoma
by: Yi-Yu Chen, et al.
Published: (2013-02-01)

Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor
by: Dae Hoon Kim, et al.
Published: (2018-11-01)

Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma
by: Sergio Gil-Rojas, et al.
Published: (2024-02-01)

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
by: Yi-Hao Yen, et al.
Published: (2023-02-01)

Quantitative proteomic profiling of hepatocellular carcinoma at different serum alpha-fetoprotein level
by: Xuyong Wei, et al.
Published: (2022-06-01)

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
by: Suryatenggara J, et al.
Published: (2017-11-01)

Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy
by: Amr Elrabat, et al.
Published: (2019-01-01)

Raised Alpha-Fetoprotein Level and its Association with Hepatocellular Carcinoma
by: Madiha Hashmi, et al.
Published: (2023-10-01)

Analysis of relation between alpha-fetoprotein and gastric cancer.
by: Sebahattin Çelik, et al.
Published: (2017-11-01)

Alpha-Fetoprotein-Producing Gastric Cancer with Nonbiliary Pancreatitis
by: Arda Yavuz, et al.
Published: (2021-01-01)

Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01)

α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk
by: Kelley Núñez, et al.
Published: (2024-01-01)

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
by: Liang L, et al.
Published: (2021-03-01)

URRENT CONCEPT OF THE STRUCTURAL AND FUNCTIONAL PROPERTIES OF ALFA-FETOPROTEIN AND THE POSSIBILITIES OF ITS CLINICAL APPLICATION
by: Gulevskyy O. K., et al.
Published: (2021-02-01)

The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
by: Takakazu Nagahara, et al.
Published: (2023-01-01)

ASSOCIATION BETWEEN ALPHA-FETOPROTEIN AND OTHER SEROLOGICAL MARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: ONE CENTER'S EXPERIENCE
by: Lejla Mehinović, et al.
Published: (2018-09-01)

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
by: Pan YX, et al.
Published: (2021-06-01)

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma
by: Yi-Hao Yen, et al.
Published: (2023-02-01)

Alpha–fetoprotein elevation in NUT midline carcinoma: a case report
by: Lorenzo D’Ambrosio, et al.
Published: (2017-04-01)